These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32236910)

  • 21. [Both formulas of Levothyrox are not bioequivalent].
    Hill C; Schlumberger M
    Rev Prat; 2019 Jun; 69(6):599-601. PubMed ID: 31626414
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adequate restitution in primary hypothyroidism depending on levothyroxine formulations].
    Tamez-Pérez HE; García-de la Cruz G; Garza-Garza LA; Tamez-Peña AL; Hernández-Coria MI; Soni-Duque D
    Rev Med Inst Mex Seguro Soc; 2018 Oct; 56(3):255-260. PubMed ID: 30376277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enantioselective resolution of thyroxine hormone by high-performance liquid chromatography utilizing a highly fluorescent chiral tagging reagent.
    Jin D; Zhang M; Jin S; Lee MK; Song GC; Back G; Lee YI
    Chirality; 2007 Aug; 19(8):625-31. PubMed ID: 17549675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication adherence and the use of new pharmaceutical formulations: the case of levothyroxine.
    Scavone C; Sportiello L; Cimmaruta D; Sullo MG; Vitelli B; Rafaniello C; Fossati T; Rossi F
    Minerva Endocrinol; 2016 Jun; 41(2):279-89. PubMed ID: 27015567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical trial of Levothyrox 50 in the treatment of hypothyroidism].
    Ben Khalifa F; Ben Abdallah N; Sellami S; el Ach K; Jedidi S; Ben Ayed H
    Tunis Med; 1985; 63(8-9):449-53. PubMed ID: 3911524
    [No Abstract]   [Full Text] [Related]  

  • 26. Charcoal hemoperfusion in the treatment of levothyroxine intoxication.
    Kreisner E; Lutzky M; Gross JL
    Thyroid; 2010 Feb; 20(2):209-12. PubMed ID: 20151829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the "French Levothyrox crisis" on signal detection in the World Health Organization pharmacovigilance database.
    Khouri C; Revol B; Lepelley M; Mallaret M; Cracowski JL
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1427-1428. PubMed ID: 30379373
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.
    Ferrara R; Ientile V; Arcoraci V; Ferrajolo C; Piccinni C; Fontana A; Benvenga S; Trifirò G
    Endocrine; 2017 Oct; 58(1):143-152. PubMed ID: 28155170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules.
    Fortner J; Salton J; Carlson C; Wheeler R; Cote B; Rao D
    Int J Pharm Compd; 2015; 19(5):414-9. PubMed ID: 26775448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comment: KCl formulations.
    Drug Intell Clin Pharm; 1987 Oct; 21(10):836-8. PubMed ID: 3428146
    [No Abstract]   [Full Text] [Related]  

  • 31. Unforeseen effect of thyroxine binding globulin when using the microencapsulated antibody method to determine free thyroxine (FT4): misleading results due to circulating unsaturated thyroxine binding globulin.
    Hashimoto T; Ishibashi K; Nagahara M; Matsubara F
    J Clin Chem Clin Biochem; 1990 Mar; 28(3):175-9. PubMed ID: 2109785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Levothyrox: a textbook case of the disregard for the patients' words].
    Deleuze J; Tenaillon A
    Rev Prat; 2019 Jun; 69(6):583. PubMed ID: 31626410
    [No Abstract]   [Full Text] [Related]  

  • 33. Novel thyroxine formulations: a further step toward precision medicine.
    Virili C; Trimboli P; Centanni M
    Endocrine; 2019 Oct; 66(1):87-94. PubMed ID: 31617168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid hormone preparations.
    Hamburger JI
    Med Trial Tech Q; 1971 Sep; 18(1):65-9. PubMed ID: 5153336
    [No Abstract]   [Full Text] [Related]  

  • 35. Stability of an extemporaneously compounded levothyroxine sodium oral liquid.
    Boulton DW; Fawcett JP; Woods DJ
    Am J Health Syst Pharm; 1996 May; 53(10):1157-61. PubMed ID: 8734676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles.
    Vaisman M; Spina LD; Eksterman LF; dos Santos MJ; Lima JS; Volpato NM; da Silva RL; de Brito AP; Noël F
    Arzneimittelforschung; 2001; 51(3):246-52. PubMed ID: 11304941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral mucositis induced by treatment with soft gel formulation of levothyroxine.
    Messina E; Ferraù F; Cannavò S
    Endocrine; 2018 Jan; 59(1):226-227. PubMed ID: 28477303
    [No Abstract]   [Full Text] [Related]  

  • 38. Potency of current levothyroxine preparations evaluated by high-performance liquid chromatography.
    Stoffer SS; Szpunar WE
    Henry Ford Hosp Med J; 1988; 36(1):64-5. PubMed ID: 3397300
    [No Abstract]   [Full Text] [Related]  

  • 39. Updating formulations for compounded oral liquid medications in a university health system.
    Stumpf JL; Leja N; Ciarkowski SL; Salah S; Schaeffler KL
    Am J Health Syst Pharm; 2018 Sep; 75(18):1394-1398. PubMed ID: 30006436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practicing yoga postures possibly increases relaxation and reduces anxiety comment to: Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian, Benjamin S. Weeks, Med Sci Monit, 2009; 15(11): RA256-262.
    Telles S
    Med Sci Monit; 2009 Dec; 15(12):LE9. PubMed ID: 19946249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.